A Narrative Review of Current and Investigational Therapies in Hypertrophic Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Pharmacology

Background:

• Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease.
• It follows an autosomal dominant inheritance pattern.
• Diagnosis relies on imaging (echocardiography, cardiac MRI) and genetic testing.

Purpose of the Study:

• To review current and investigational treatments for hypertrophic cardiomyopathy.
• To highlight recent advancements in managing this prevalent inherited cardiac condition.

Main Methods:

• Literature review of pharmacological and invasive therapies.
• Inclusion of approved treatments such as cardiac myosin inhibitors.
• Discussion of emerging approaches like radiofrequency ablation and gene editing.

Main Results:

• Significant advancements in HCM management are transforming patient care.
• New therapeutic options offer improved treatment strategies.
• Ongoing clinical trials are exploring novel investigational therapies.

Conclusions:

• Current and future treatments offer new hope for hypertrophic cardiomyopathy patients.
• The landscape of HCM management is rapidly evolving.
• Further research and clinical trials are crucial for optimizing outcomes.